BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28988984)

  • 1. Prevention of chronic renal allograft rejection by AS2553627, a novel JAK inhibitor, in a rat transplantation model.
    Nakamura K; Kawato Y; Kaneko Y; Hanaoka K; Kubo K; Nakanishi T; Maeda M; Fukahori H; Ito M; Noto T; Inami M; Hirose J; Morokata T
    Transpl Immunol; 2018 Feb; 46():14-20. PubMed ID: 28988984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement of mycophenolate mofetil with a JAK inhibitor, AS2553627, in combination with low-dose tacrolimus, for renal allograft rejection in non-human primates.
    Nakamura K; Oshima S; Maeda M; Morio H; Fukahori H; Nakanishi T; Tsujimoto S; Hirose J; Noto T; Hamakawa N; Inami M; Morokata T
    Int Immunopharmacol; 2018 Nov; 64():201-207. PubMed ID: 30195818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AS2553627, a novel JAK inhibitor, prevents chronic rejection in rat cardiac allografts.
    Nakamura K; Inami M; Morio H; Okuma K; Ito M; Noto T; Shirakami S; Hirose J; Morokata T
    Eur J Pharmacol; 2017 Feb; 796():69-75. PubMed ID: 27993641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chronic renal rejection model with a fully MHC-mismatched rat strain combination under immunosuppressive therapy.
    Hanaoka K; Kawato Y; Kubo K; Nakanishi T; Maeda M; Nakamura K; Hirose J; Noto T; Fukahori H; Fujikawa A; Miyoshi S; Takakura S; Morokata T; Higashi Y
    Transpl Immunol; 2016 Sep; 38():19-26. PubMed ID: 27545900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant reduction of acute cardiac allograft rejection by selective janus kinase-1/3 inhibition using R507 and R545.
    Deuse T; Hua X; Taylor V; Stubbendorff M; Baluom M; Chen Y; Park G; Velden J; Streichert T; Reichenspurner H; Robbins RC; Schrepfer S
    Transplantation; 2012 Oct; 94(7):695-702. PubMed ID: 22971540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AEB-071 versus tacrolimus monotherapy to prevent acute cardiac allograft rejection in the rat: a preliminary report.
    Fang YH; Joo DJ; Lim BJ; Kim JY; Kim MS; Jeong HJ; Kim YS
    Transplant Proc; 2010 Apr; 42(3):976-9. PubMed ID: 20430219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection.
    Rovira J; Ramírez-Bajo MJ; Banon-Maneus E; Lazo-Rodríguez M; Moya-Rull D; Hierro-Garcia N; Tubita V; Piñeiro GJ; Revuelta I; Ventura-Aguiar P; Cucchiari D; Oppenheimer F; Brunet M; Campistol JM; Diekmann F
    Transplantation; 2018 Jul; 102(7):1075-1084. PubMed ID: 29620612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of AEB071 (sotrastaurin) with tacrolimus on rat heterotopic cardiac allograft rejection and survival.
    Fang YH; Joo DJ; Lim BJ; Huh KH; Kim MS; Suh H; Kim YS
    J Surg Res; 2011 Nov; 171(1):e133-7. PubMed ID: 21816421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.
    Szabo A; Lutz J; Schleimer K; Antus B; Hamar P; Philipp T; Heemann U
    Kidney Int; 2000 Mar; 57(3):982-91. PubMed ID: 10720951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
    Zhang W; Liu M; Wu Y; Zhu P; Yin C; Zhang W; Gu M
    J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early application of Met-RANTES ameliorates chronic allograft nephropathy.
    Song E; Zou H; Yao Y; Proudfoot A; Antus B; Liu S; Jens L; Heemann U
    Kidney Int; 2002 Feb; 61(2):676-85. PubMed ID: 11849411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
    Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
    Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a novel inducible nitric oxide synthase inhibitor in prevention of rat chronic aortic rejections.
    Ouyang J; Xu D; Zhang X; Qi S; Ma A; Jiang W; Chida N; Sudo Y; Tamura K; Daloze P; Chen H
    Transplantation; 2005 May; 79(10):1386-92. PubMed ID: 15912108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus.
    Ferreira A; Felipe C; Cristelli M; Viana L; Basso G; Stopa S; Mansur J; Ivani M; Bessa A; Ruppel P; Aguiar W; Campos E; Gerbase-DeLima M; Proença H; Tedesco-Silva H; Medina-Pestana J
    Am J Nephrol; 2017; 45(6):497-508. PubMed ID: 28511172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.
    Bilolo KK; Ouyang J; Wang X; Zhu S; Jiang W; Qi S; Xu D; Hebert MJ; Bekersky I; Fitzsimmons WE; Chen H
    Transplantation; 2003 Jun; 75(11):1881-7. PubMed ID: 12811249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy.
    Kühne L; Jung B; Poth H; Schuster A; Wurm S; Ruemmele P; Banas B; Bergler T
    BMC Immunol; 2017 Dec; 18(1):52. PubMed ID: 29258420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
    Li J; Basler M; Alvarez G; Brunner T; Kirk CJ; Groettrup M
    Kidney Int; 2018 Mar; 93(3):670-680. PubMed ID: 29229189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts.
    Hancock WH; Whitley WD; Tullius SG; Heemann UW; Wasowska B; Baldwin WM; Tilney NL
    Transplantation; 1993 Sep; 56(3):643-50. PubMed ID: 8105570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of chronic rejection by pravastatin in a rat kidney transplant model.
    Ji P; Si MS; Podnos Y; Chow H; Steward E; Imagawa DK
    Transplantation; 2002 Sep; 74(6):821-7. PubMed ID: 12364863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.